An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...
Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...
Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...
Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...
The agreement grants ALK exclusive global rights to the neffy ® adrenaline (epinephrine) nasal spray, with exception of the USA, Australia, New Zealand, Japan and China. The deal delivers on key ...
An alternative, nasal spray, formulation has been developed that demonstrates good efficacy, high tolerability and a very fast onset of action. This study assessed the pharmacokinetics and ...
ALK-Abelló has acquired rights to Neffy adrenaline nasal spray in Europe and Canada, amongst other countries, from ARS ...
ARS Pharmaceuticals shares jumped Monday after the company inked a deal to commercialize its allergic reaction nasal spray internationally.
Amanda Gardner is a freelance health reporter whose stories have appeared in cnn.com, health.com, cnn.com, WebMD, HealthDay, Self Magazine, the New York Daily News, Teachers & Writers Magazine ...
Recent outbreaks of Legionnaires’ disease have been linked to cruise ship hot tubs, according to CDC reports. Infectious ...
US President Donald Trump has been lambasted by the medical community after suggesting research into whether coronavirus might be treated by injecting disinfectant into the body. He also appeared ...